Cyclic amine phenyl beta-3 adrenergic receptor agonists

Details Cyclic amine phenyl beta-3 adrenergic receptor agonists Cyclic amine phenyl beta-3 adrenergic receptor agonists

2006-04-04

2006-04-04

Desai, Rita (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S223000, C546S224000, C546S193000, C546S209000, C546S212000, C514S318000, C514S326000

Reexamination Certificate

active

07022716

ABSTRACT:
This invention provides compounds of Formula I having the structurewherein,R1, R2, R3, R4, R5, T, T1, T2, and X are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.

REFERENCES:
patent: 4526786 (1985-07-01), Bourgery et al.
patent: 4813998 (1989-03-01), Van Lommen et al.
patent: 5153210 (1992-10-01), Ainsworth et al.
patent: 5296485 (1994-03-01), Lubisch et al.
patent: 5561142 (1996-10-01), Fisher et al.
patent: 5578620 (1996-11-01), Fujita et al.
patent: 5614523 (1997-03-01), Audia et al.
patent: 5741789 (1998-04-01), Hibschman
patent: 5786356 (1998-07-01), Bell et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5998452 (1999-12-01), Ohi et al.
patent: 6069176 (2000-05-01), Tsuchiya et al.
patent: 6150378 (2000-11-01), Chatterjee et al.
patent: 6214842 (2001-04-01), Malamas et al.
patent: 6288231 (2001-09-01), Chatterjee et al.
patent: 6346532 (2002-02-01), Maruyama et al.
patent: 6395762 (2002-05-01), Fobare et al.
patent: 6410734 (2002-06-01), Hu
patent: 6444685 (2002-09-01), Sum et al.
patent: 6451814 (2002-09-01), Ashwell et al.
patent: 6458817 (2002-10-01), Quagliato et al.
patent: 6867220 (2005-03-01), Cecchi
patent: 2002/0022605 (2002-02-01), Sum et al.
patent: 2002/0022638 (2002-02-01), Ashwell et al.
patent: 2002/0022641 (2002-02-01), Fobare et al.
patent: 2002/0028835 (2002-03-01), Hu et al.
patent: 2002/0037907 (2002-03-01), Steffan et al.
patent: 2002/0068751 (2002-06-01), Coghlan et al.
patent: 0 089 154 (1983-09-01), None
patent: 0 236 624 (1987-09-01), None
patent: 0 449 261 (1991-10-01), None
patent: 0 590 793 (1994-04-01), None
patent: 0 659 737 (1995-06-01), None
patent: 0 714 883 (1996-06-01), None
patent: 0 764 640 (1997-03-01), None
patent: 0 801 060 (1997-10-01), None
patent: 2 798 126 (2001-03-01), None
patent: 2 163 150 (1986-02-01), None
patent: WO 95/29159 (1995-11-01), None
patent: WO 97/41120 (1997-11-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/09625 (1998-03-01), None
patent: WO 98/22480 (1998-05-01), None
patent: WO 98/32753 (1998-07-01), None
patent: WO 99/65895 (1999-12-01), None
patent: WO 01/17989 (2001-03-01), None
patent: WO 01/43744 (2001-06-01), None
patent: WO 01/44227 (2001-06-01), None
Marc S. Berrdige et al., Nucl. Med. Biol., 1992, 563-569, 19(5).
Joan M. Caroon et al., J. Pharm. Sci., Jan. 1987, 32-34, 76(1).
A. Guy et al., Synthesis, Sep. 1992, 821-22.
Manabu Hori et al., J. Org. Chem., 1998, 889-894, 63.
Yunsheng Huang et al., J. Med. Chem., 1998, 2361-2370, 41.
Bernard Hulin et al., J. Med. Chem., 1992, 1853-1864, 35.
Carl Kaiser et al., J. Med. Chem., 1977, 687-692, 20(5).
Yutaka Kawashima et al., Chem. Pharm. Bull, 1995, 1132-1136, 43(7).
Kiyoto Koguro et al., Synthesis, 1998, 910-914.
Gerard Leclerc et al., J. Med. Chem., 1980, 738-744, 23(7).
D. Mauleon et al., II Farmaco, 1109-1117, 44(11).
Alexander McKillop et al., J. Am. Chem. Soc., Sep. 1971, 4919-4920, 93(19).
Ricardo Tapia et al., Synthetic Communications, 1986, 681-687, 16(6).
Edward C. Taylor et al., Synthesis, Aug. 1981, 606-608.
Michiaki Tominaga et al., Chem. Pharm. Bull, 1987, 3699-3704, 35(9).
R.H. Uloth et al., J. Med. Chem., 1966, 88-97, 9.
Paul C. Unangst et al., J. Med. Chem., 1994, 322-328, 37.
Sophie Vanwetswinkel et al., J. Anitbiotics, Sep. 1994, 1041-1051, 47(9).
S. Tamada et al., JP 01061468 A2 (English abstract), 1989.
Michael S. Malamas et al., Medical Chemistry Research, 10(3), 164-177 (2000).
Ann E. Weber et al., Bioorganic & Medicinal Chemistry Letters, 8, 1101-1106, (1998).
Baihua Hu et al., Bioorganic & Medicinal Chemistry Letters, 11, 981-984 (20021).
K. Anji Reddy et al., Bioorganic & Medicinal Chemistry Letters, 8, 999-1002 (1998).
Barrie Cantello et al., J. Med. Chem., 37, 3977-3985 (1994).
Abstract of WO 99/25687A1, Accession No. 1999:350651 Caplus (1999).
Baihua Hu et al., J. Med. Chem., 44, 1456-1466 (2001).
Abstract of Papers American Chemical Society, 221, 1-2, (2001).

Affiliated with

Also associated with

Rating

Cyclic amine phenyl beta-3 adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic amine phenyl beta-3 adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amine phenyl beta-3 adrenergic receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3581482